TrianglePUBLICATIONS · 25349301
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2014 Dec 1
- First author
- O'Shaughnessy J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- O'Shaughnessy J
- type
- Author
- name
- Schwartzberg L
- type
- Author
- name
- Danso MA
- type
- Author
- name
- Miller KD
- type
- Author
- name
- Rugo HS
- type
- Author
- name
- Neubauer M
- type
- Author
- name
- Robert N
- type
- Author
- name
- Hellerstedt B
- type
- Author
- name
- Saleh M
- type
- Author
- name
- Richards P
- type
- Author
- name
- Specht JM
- type
- Author
- name
- Yardley DA
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- O'Shaughnessy J
- type
- Author
- name
- Schwartzberg L
- type
- Author
- name
- Danso MA
- type
- Author
- name
- Miller KD
- type
- Author
- name
- Rugo HS
- type
- Author
- name
- Neubauer M
- type
- Author
- name
- Robert N
- type
- Author
- name
- Hellerstedt B
- type
- Author
- name
- Saleh M
- type
- Author
- name
- Richards P
- type
- Author
- name
- Specht JM
- type
- Author
- name
- Yardley DA
- type
- Author
- bibliography ids
- nci-bib-282ddbb47e4bba4a8cfaa92d
- book metadata
- content sha256
- 3d07658119def4eb51ec782a58cc9acb47659ca01ae3afdc6a09d546d948e91c
- document type
- citation
- dois
- 10.1200/JCO.2014.55.2984
- electronic publication date
- display
- 2014 Oct 27
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25349301
- immutable id
- pubmed:25349301@3d07658119def4eb51ec782a58cc9acb47659ca01ae3afdc6a09d546d948e91c
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 34
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3840-7
- volume
- 32
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25349301
- provenance
- batch id
- 863b068fe5a07222af6a
- provider
- NCBI PubMed ESummary
- record sha256
- 11f04606e57bbf41013d0e86a05132fa096041e8612a5801889edf7c3a7fd41d
- response sha256
- 80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
- retrieved at
- 2026-09-09T23:47:07.648963+00:00
- publication date
- display
- 2014 Dec 1
- precision
- day
- year
- 2014
- publication types
- Clinical Trial, Phase III
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
Preserved source evidence · Not medical advice